US$7.42m (down 19% from 1Q 2023). Profit margin: 2.5% (down from 3.1% in 1Q 2023). The decrease in margin was driven by ...
CRISPR Therapeutics (CRSP) delivered earnings and revenue surprises of 12.27% and 93.94%, respectively, for the quarter ended ...
U.S. stock index futures slipped on Thursday as Treasury yields rose further ahead of jobless claims data that could provide a clearer picture of the Federal Reserve's interest rate agenda for the ...
U.S. stock index futures slipped on Thursday as Treasury yields rose further ahead of jobless claims data that could provide ...
GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading destination for prescription savings in the U.S., has released ...
Investors want stability as much as prosperity in the constantly shifting stock market. The investment philosophy of renowned ...
GE Vernova has a large backlog in equipment and services, positioning it well to benefit from the increasing demand for power ...
Nvidia stock has already minted many millionaires, but its next earnings report could be a make-or-break period for the ...
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today reported financial results for first quarter 2024 and provided a business update. "In the first quarter, ...
Dubai, UAE: According to the EY MENA IPO Eye Q1 2024 report, IPO activity in the MENA region retained strong momentum. The ...
Erik Holmlin; President, Chief Executive Officer, Director; Bionano Genomics Inc Gulsen Kama; Chief Financial Officer; Bionano Genomics Inc Sung Ji Nam; Analyst; Scotiabank GBM Operator Good day and ...
David Patience; Chief Financial Officer; Accelerate Diagnostics Inc ...